BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24015712)

  • 21. Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database.
    Paul S; Sedrakyan A; Chiu YL; Nasar A; Port JL; Lee PC; Stiles BM; Altorki NK
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):813-7. PubMed ID: 22826474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).
    Colice GL; Shafazand S; Griffin JP; Keenan R; Bolliger CT;
    Chest; 2007 Sep; 132(3 Suppl):161S-77S. PubMed ID: 17873167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.
    Voltolini L; Bongiolatti S; Luzzi L; Bargagli E; Fossi A; Ghiribelli C; Rottoli P; Gotti G
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e17-23. PubMed ID: 23129356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung resection in patients with preoperative FEV1 < 35% predicted.
    Linden PA; Bueno R; Colson YL; Jaklitsch MT; Lukanich J; Mentzer S; Sugarbaker DJ
    Chest; 2005 Jun; 127(6):1984-90. PubMed ID: 15951309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
    Almquist D; Khanal N; Smith L; Ganti AK
    Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer?
    Zuin A; Andriolo LG; Marulli G; Schiavon M; Nicotra S; Calabrese F; Romanello P; Rea F
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e120-5; discussion e125. PubMed ID: 23657547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy.
    Cao C; Louie BE; Melfi F; Veronesi G; Razzak R; Romano G; Novellis P; Ranganath NK; Park BJ
    Eur J Cardiothorac Surg; 2020 Feb; 57(2):338-342. PubMed ID: 31332434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Video-assisted thoracoscopic lobectomy: state of the art and future directions.
    Shaw JP; Dembitzer FR; Wisnivesky JP; Litle VR; Weiser TS; Yun J; Chin C; Swanson SJ
    Ann Thorac Surg; 2008 Feb; 85(2):S705-9. PubMed ID: 18222201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.
    Berry MF; Villamizar-Ortiz NR; Tong BC; Burfeind WR; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2010 Apr; 89(4):1044-51; discussion 1051-2. PubMed ID: 20338305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers].
    Mondello B; Sibilio M; Pavone A; Monaco F; Nunnari F; Micali V; Vasta I; Perrone O; Monaco M
    G Chir; 2007; 28(1-2):7-12. PubMed ID: 17313726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative assessment as a predictor of mortality and morbidity after lung resection.
    Markos J; Mullan BP; Hillman DR; Musk AW; Antico VF; Lovegrove FT; Carter MJ; Finucane KE
    Am Rev Respir Dis; 1989 Apr; 139(4):902-10. PubMed ID: 2930068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.
    Petersen RP; Pham D; Toloza EM; Burfeind WR; Harpole DH; Hanish SI; D'Amico TA
    Ann Thorac Surg; 2006 Jul; 82(1):214-8; discussion 219. PubMed ID: 16798217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minute ventilation-to-carbon dioxide output (VE/VCO2) slope is the strongest predictor of respiratory complications and death after pulmonary resection.
    Brunelli A; Belardinelli R; Pompili C; Xiumé F; Refai M; Salati M; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1802-6. PubMed ID: 22560968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patients.
    Gopaldas RR; Bakaeen FG; Dao TK; Walsh GL; Swisher SG; Chu D
    Ann Thorac Surg; 2010 May; 89(5):1563-70. PubMed ID: 20417778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.
    Berry MF; Yang CJ; Hartwig MG; Tong BC; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2015 Jul; 100(1):271-6. PubMed ID: 25986099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV₁ and diffusing capacity of the lung for carbon monoxide < 40%.
    Puente-Maestú L; Villar F; González-Casurrán G; Moreno N; Martínez Y; Simón C; Peñalver R; González-Aragoneses F
    Chest; 2011 Jun; 139(6):1430-1438. PubMed ID: 20930005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.
    Ceppa DP; Kosinski AS; Berry MF; Tong BC; Harpole DH; Mitchell JD; D'Amico TA; Onaitis MW
    Ann Surg; 2012 Sep; 256(3):487-93. PubMed ID: 22868367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.